Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Christine Castro, Neil Rothstein, Jonathan Ward, Patrick Terry


Direct-to-consumer genetic testing firm 23andMe announced several new appointments to its executive team, including Christine Castro as VP of communications, Neil Rothstein as VP of marketing, and Jonathan Ward as VP of strategic alliances.

Before joining 23andMe, Castro was VP of corporate relations at Genentech, chief communications officer for Yahoo! Inc., and VP of corporate communications at The Walt Disney Company.

Rothstein worked at Netflix for 11 years before coming to 23andMe. Most recently, he served as VP of online marketing at Netflix.

Ward was interim chief marketing officer at before coming to 23andMe and has held marketing and business development positions at America Online, McKinsey & Company, as well as Ogilvy, Adams & Rinehart.

Patrick Terry this week announced he is leaving consulting firm Scientia Advisors, where he was head of the pricing, reimbursement, and market access practice.

Upon his departure from Scientia, Terry plans to take some personal time, and then depart for a speaking tour through China in November. Hebei United University in Tangshan, China, has awarded Terry with an honorary post as professor of medical sciences. Terry will be speaking throughout the country about personalized medicine.

Terry is best known for having started a number of life sciences-focused organizations and companies. In 2000, Terry was among a group of life sciences leaders that founded the molecular diagnostics firm Genomic Health.

After this, Terry plans to return to founding and investing in new healthcare and technology companies.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.